President Trump's tariff plans aimed at Mexico and Canada were partly justified by the desire to reduce fentanyl influx into the U.S. Despite a decrease in seized fentanyl, overdose deaths remain alarmingly high, highlighting the need for more effective addiction treatment like buprenorphine, which has been underprescribed. Critics argue that solely targeting supply ignores the underlying issues of American demand for opioids. A medication-based treatment approach is suggested as a key strategy to reduce such demand and prevent fatal overdoses, marking a need for a broader understanding of the crisis.
In his actions and rhetoric, Trump seems to emphasize the reduction of supply as the answer to the fentanyl crisis.
A wealth of evidence suggests that a medication-based approach using buprenorphine is much more effective at preventing overdose deaths than abstinence-based approaches.
Collection
[
|
...
]